Article Details
Retrieved on: 2022-06-17 02:17:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ: INMB) (the "Company"), a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system ...
Article found on: www.marketscreener.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here